PT95911B - Processo para preparacao de vectores geneticos da expressao do factor de crescimento dos nervos em celulas eucarioticas - Google Patents

Processo para preparacao de vectores geneticos da expressao do factor de crescimento dos nervos em celulas eucarioticas Download PDF

Info

Publication number
PT95911B
PT95911B PT95911A PT9591190A PT95911B PT 95911 B PT95911 B PT 95911B PT 95911 A PT95911 A PT 95911A PT 9591190 A PT9591190 A PT 9591190A PT 95911 B PT95911 B PT 95911B
Authority
PT
Portugal
Prior art keywords
human
vector
cells
promoter
gene
Prior art date
Application number
PT95911A
Other languages
English (en)
Portuguese (pt)
Other versions
PT95911A (pt
Inventor
Francesco Della Valle
Lanfranco Callegaro
Alessandro Negro
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of PT95911A publication Critical patent/PT95911A/pt
Publication of PT95911B publication Critical patent/PT95911B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT95911A 1989-11-16 1990-11-15 Processo para preparacao de vectores geneticos da expressao do factor de crescimento dos nervos em celulas eucarioticas PT95911B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04856489A IT1238348B (it) 1989-11-16 1989-11-16 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.

Publications (2)

Publication Number Publication Date
PT95911A PT95911A (pt) 1991-09-13
PT95911B true PT95911B (pt) 1998-01-30

Family

ID=11267348

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95911A PT95911B (pt) 1989-11-16 1990-11-15 Processo para preparacao de vectores geneticos da expressao do factor de crescimento dos nervos em celulas eucarioticas

Country Status (22)

Country Link
US (1) US5457034A (https=)
EP (1) EP0432510B1 (https=)
JP (2) JP3121611B2 (https=)
KR (1) KR910009929A (https=)
CN (1) CN1051934A (https=)
AR (1) AR246983A1 (https=)
AT (1) ATE214735T1 (https=)
CA (1) CA2030108C (https=)
DE (1) DE69033937T2 (https=)
ES (1) ES2173856T3 (https=)
FI (1) FI905691L (https=)
HU (1) HUT61047A (https=)
IE (1) IE904120A1 (https=)
IL (1) IL96347A (https=)
IT (1) IT1238348B (https=)
NZ (1) NZ236058A (https=)
PE (1) PE28191A1 (https=)
PL (1) PL287811A1 (https=)
PT (1) PT95911B (https=)
TW (1) TW205069B (https=)
YU (1) YU217890A (https=)
ZA (1) ZA909122B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
AU1447600A (en) * 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
DE60040678D1 (en) 1999-09-29 2008-12-11 Gen Hospital Corp Parathyroid hormon (pth) polypeptidderivate
EP1305040B1 (en) * 2000-07-28 2009-09-09 Christopher J. Murphy Transplant media
CA2454275C (en) * 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US7795220B2 (en) 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
CN101260398B (zh) * 2007-03-07 2013-06-05 舒泰神（北京）生物制药股份有限公司 神经生长因子基因定位改造动物及其制备方法和应用
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
CN101927012B (zh) * 2009-06-26 2013-08-14 丽珠医药集团股份有限公司 神经生长因子的病毒灭活方法
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
CN102816766A (zh) * 2012-05-04 2012-12-12 沈阳医学院 蛇毒神经生长因子活性多肽的筛选方法
JP2024527197A (ja) * 2021-07-30 2024-07-23 チェンドゥ ユノヴェル バイオファーマ カンパニー リミテッド． 組換えｃｈｏ細胞、その構築方法、並びにそれを用いた検出システム及び方法
CN115894705A (zh) * 2021-09-30 2023-04-04 三生国健药业（上海）股份有限公司 一种β-NGF融合蛋白、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4796580A (en) * 1987-09-11 1989-01-10 Allied-Signal Inc. Idle control valve for use with a throttle assembly of an internal combustion engine
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
YU217890A (sh) 1993-05-28
PT95911A (pt) 1991-09-13
JPH03224490A (ja) 1991-10-03
ES2173856T3 (es) 2002-11-01
IL96347A0 (en) 1991-08-16
FI905691A7 (fi) 1991-05-17
IL96347A (en) 1997-11-20
KR910009929A (ko) 1991-06-28
IT8948564A1 (it) 1991-05-16
CA2030108C (en) 1998-04-28
JP3121611B2 (ja) 2001-01-09
EP0432510B1 (en) 2002-03-20
TW205069B (https=) 1993-05-01
DE69033937D1 (de) 2002-04-25
ZA909122B (en) 1991-09-25
HU907174D0 (en) 1991-05-28
AU645998B2 (en) 1994-02-03
US5457034A (en) 1995-10-10
IT1238348B (it) 1993-07-13
EP0432510A1 (en) 1991-06-19
FI905691A0 (fi) 1990-11-16
IT8948564A0 (it) 1989-11-16
PL287811A1 (en) 1991-12-02
NZ236058A (en) 1993-04-28
ATE214735T1 (de) 2002-04-15
AR246983A1 (es) 1994-10-31
JP2001000194A (ja) 2001-01-09
HUT61047A (en) 1992-11-30
CA2030108A1 (en) 1991-05-17
FI905691L (fi) 1991-05-17
AU6655890A (en) 1991-05-23
PE28191A1 (es) 1991-10-28
DE69033937T2 (de) 2002-11-14
IE904120A1 (en) 1991-05-22
CN1051934A (zh) 1991-06-05

Similar Documents

Publication Publication Date Title
PT95911B (pt) Processo para preparacao de vectores geneticos da expressao do factor de crescimento dos nervos em celulas eucarioticas
US20210269506A1 (en) Polynucleotides encoding immune modulating polypeptides
US9925277B2 (en) Polynucleotide compositions containing amino acids
DE60115613T2 (de) Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien
EP0369943B1 (en) Binding protein for insulin-like growth factors
US20170173128A1 (en) Targeted adaptive vaccines
BR112014016076B1 (pt) Peptídeo, vetor, construção de peptídeo quimérico e composição farmacêutica
CA2311681A1 (en) Human interferon-epsilon: a type i interferon
PT87721B (pt) Provesso para a preparacao de novas proteinas com actividade de factor viii, de composicoes farmaceuticas que as contem, de sequencias de adn que codificam para estas proteinas e de vectores que contem estas sequencias de adn
TW201305219A (zh) 胜肽衍生物
AU2021266345A1 (en) Protoxin-II variants and methods of use
CN104774269A (zh) 改良型人凝血因子FVII-Fc融合蛋白及其制备方法与用途
BRPI0517932B1 (pt) Muteína humana de beta-interferon, polinucleotídeo, vetor de expressão, célula animal, método para preparação de referida muteína e composição farmacêutica compreedendo a mesma
US5432261A (en) Motlin-like polypeptide and use thereof
HK1251001A1 (zh) Il-37变体
EP2776458B1 (en) Protease activated receptor-1 (par1) derived cytoprotective polypeptides and related methods
JPS63102699A (ja) 新規なｄａｆの製造のための核酸
JP5100662B2 (ja) Ｂｍｐ−７変異体組成物、方法および使用
DE69925271T2 (de) Angiostatin-bindendes protein
CA2038208A1 (en) Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
US20220153781A1 (en) Tumor Targeting Polypeptide and Method of Use Thereof
JP6906497B2 (ja) 変異型ヒトエリスロポエチンの製造方法
US5459049A (en) Motilin-like polypeptide and use thereof
DE60021421T2 (de) APOPTOSE-HEMMENDES POLYPEPTID, FüR DIESES KODIERENDE GENE UND POLYNUKLEOTIDE UND DIESE BEINHALTENDE ZUSAMMENSETZUNGEN
CN121538222A (zh) mRNA药物及其在治疗肺动脉高压中的应用

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910405

FG3A Patent granted, date of granting

Effective date: 19971022